Lumiliximab

Lumiliximab
Lumiliximab is a chimeric monoclonal antibody which is used as an immunosuppressive drug.

Wikipedia, the free encyclopedia © 2001-2006 Wikipedia contributors (Disclaimer)
This article is licensed under the GNU Free Documentation License.
Last updated on Thursday May 08, 2008 at 13:58:24 PDT (GMT -0700)
View this article at Wikipedia.org - Edit this article at Wikipedia.org - Donate to the Wikimedia Foundation

Related Articles
New chronic lymphocytic leukemia therapy study findings reported from N.I. Pathan and co-authors.(Report)
Mar 17, 2008; New investigation results, 'Mediation of apoptosis by and antitumor activity of Lumiliximab in chronic lymphocytic...
Read more with a free trial on HighBeam.com »
Report summarizes chronic lymphocytic leukemia therapy study findings from Ohio State University, Comprehensive Cancer Center.
Feb 11, 2010; Researchers detail in 'Phase 1/2 study of Lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in...
Read more with a free trial on HighBeam.com »
Findings from Ohio State University, Comprehensive Cancer Center in Lymphocytic Leukemia Reported.
Feb 07, 2011; Data detailed in 'Phase 1/2 study of Lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients...
Read more with a free trial on HighBeam.com »
Market Focus: Biotech explores a new frontier.(biotechnology industries using online tactics to reach the consumers)
Apr 02, 2007; Companies in the sector are embracing the online world in their efforts to better reach patients, investors, and potential...
Read more with a free trial on HighBeam.com »
BUSINESS IN BRIEF
Dec 12, 2006; THE REGION Idera Pharmaceuticals sells licenses to MerckIdera Pharmaceuticals Inc. of Cambridge signed a drug-development deal...
Read more with a free trial on HighBeam.com »
HighBeam Research, Inc. © Copyright 2009.

Search another word or see Lumiliximabon Dictionary | Thesaurus |Spanish
  • Please Login or Sign Up to use the Recent Searches feature
FAVORITES
RECENT